Johnson & Johnson, a pharmaceutical company, has joined the ranks of companies that require U.S. health regulators to develop basic safety rules for cannabinoids in food and dietary supplements. On Tuesday, a senior executive of the Pharmaceutical Department of the company said in a speech to the Advisory Group of the U.S. Food and Drug Administration (FDA) that the FDA should begin to resolve the outstanding issues related to cannabinoids such as CBD. He said that the FDA could consider taking temporary measures to collect more data on the safety of over-the-counter cannabinoids. The FDA Scientific Committee considered cannabinoids at a hearing on Tuesday to assess obstacles to cannabinoids being sold without a prescription. Stevenmusser, deputy director of the FDA Center for food safety and applied nutrition, said consumers want health officials to monitor but not ban cannabinoid products. According to hemp telegram, muser said: "they want to own these products and do not want to be prohibited from owning these products, although they do want a certain degree of supervision and protection, so they want someone to supervise the quality, safety and purity."
Source: mjbizdaily com/